Arrowstreet Capital’s Ultralife ULBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$801K Hold
126,753
﹤0.01% 1680
2026
Q1
$826K Sell
126,753
-9,708
-7% -$60.3K ﹤0.01% 1597
2025
Q4
$781K Sell
136,461
-82,557
-38% -$509K ﹤0.01% 1602
2025
Q3
$1.49M Buy
219,018
+148,542
+211% +$1.13M ﹤0.01% 1513
2025
Q2
$633K Buy
70,476
+58,211
+475% +$345K ﹤0.01% 1700
2025
Q1
$66K Sell
12,265
-6,378
-34% -$43.4K ﹤0.01% 1774
2024
Q4
$139K Hold
18,643
﹤0.01% 1678
2024
Q3
$169K Sell
18,643
-37,220
-67% -$384K ﹤0.01% 1659
2024
Q2
$593K Sell
55,863
-26,281
-32% -$280K ﹤0.01% 1311
2024
Q1
$724K Hold
82,144
﹤0.01% 1382
2023
Q4
$560K Hold
82,144
﹤0.01% 1207
2023
Q3
$802K Buy
+82,144
New +$658K ﹤0.01% 1033

Other funds holding ULBI

Arrowstreet Capital's ULBI Position: Q2 2026 in Review

Arrowstreet Capital held its Ultralife (ULBI) position steady in Q2 2026 at 126,753 shares worth $801K. The position accounts for ﹤0.01% of the portfolio, ranked #1680.

Arrowstreet Capital first reported a position in ULBI in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.49M in Q3 2025. 52 funds tracked by Wall St. Rank hold ULBI as of Q2 2026.

  • Arrowstreet Capital held 126,753 shares of Ultralife worth $801K as of Q2 2026.
  • Arrowstreet Capital left its Ultralife share count unchanged in Q2 2026.
  • Ultralife made up ﹤0.01% of Arrowstreet Capital's portfolio in Q2 2026, its #1680 holding.
  • Arrowstreet Capital first reported a position in Ultralife in Q3 2023 and has held it in 12 quarters since.
  • Arrowstreet Capital's Ultralife position peaked at $1.49M in Q3 2025.
  • 52 funds tracked by Wall St. Rank held Ultralife as of Q2 2026.

Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.